Stocktoria

ALUMIS INC. ALMS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-06-28

ALUMIS INC. statistics & valuation

Market cap$3.4B
P / B11.2×
Net margin-1011.7%
Return on equity-80.8%
FCF margin-1539.2%
Return on capital-134%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1011.70% 202320242025
Gross margin (%)
202320242025
Operating margin (%)
-1886.90% 202320242025
Return on equity (%)
-113.10% -80.80% 202320242025
Shares outstanding
2.2M 28.3M 85.0M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-173.00% -86.30% -59.10% 202320242025
Free cash flow margin (%)
-1539.20% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$72.08 -$10.38 -$2.86 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Operating margin-1886.9%——
Net margin-1011.7%——
FCF margin-1539.2%——
Return on assets-59.1%-86.3%-173.0%
Return on equity-80.8%-113.1%45.7%
Current ratio4.346.012.56

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.